BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14659635)

  • 21. Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds.
    Bartel C; Bytzek AK; Scaffidi-Domianello YY; Grabmann G; Jakupec MA; Hartinger CG; Galanski MS; Keppler BK
    J Biol Inorg Chem; 2012 Mar; 17(3):465-74. PubMed ID: 22227950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
    Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).
    Hall MD; Daly HL; Zhang JZ; Zhang M; Alderden RA; Pursche D; Foran GJ; Hambley TW
    Metallomics; 2012 Jun; 4(6):568-75. PubMed ID: 22569908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells.
    Kishimoto S; Yasuda M; Suzuki R; Fukushima S
    Biometals; 2016 Dec; 29(6):1075-1083. PubMed ID: 27787693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin.
    Xing R; Wang X; Zhang C; Zhang Y; Wang Q; Yang Z; Guo Z
    J Inorg Biochem; 2009 Jul; 103(7):1039-44. PubMed ID: 19501911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
    Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
    Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
    Westendorf AF; Bodtke A; Bednarski PJ
    Dalton Trans; 2011 May; 40(19):5342-51. PubMed ID: 21461431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin.
    Morrison JG; White P; McDougall S; Firth JW; Woolfrey SG; Graham MA; Greenslade D
    J Pharm Biomed Anal; 2000 Dec; 24(1):1-10. PubMed ID: 11108533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes.
    Savić A; Filipović L; Aranđelović S; Dojčinović B; Radulović S; Sabo TJ; Grgurić-Šipka S
    Eur J Med Chem; 2014 Jul; 82():372-84. PubMed ID: 24927057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of a liposomal oxaliplatin drug formulation by capillary electrophoresis hyphenated to inductively coupled plasma mass spectrometry (CE-ICP-MS).
    Nguyen TT; Østergaard J; Stürup S; Gammelgaard B
    Anal Bioanal Chem; 2012 Feb; 402(6):2131-9. PubMed ID: 22245979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
    Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
    Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
    J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.
    Monti E; Gariboldi M; Maiocchi A; Marengo E; Cassino C; Gabano E; Osella D
    J Med Chem; 2005 Feb; 48(3):857-66. PubMed ID: 15689170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
    Rice JR; Gerberich JL; Nowotnik DP; Howell SB
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.
    Buß I; Kalayda GV; Lindauer A; Reithofer MR; Galanski MS; Keppler BK; Jaehde U
    J Biol Inorg Chem; 2012 Jun; 17(5):699-708. PubMed ID: 22456982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
    Samimi G; Safaei R; Katano K; Holzer AK; Rochdi M; Tomioka M; Goodman M; Howell SB
    Clin Cancer Res; 2004 Jul; 10(14):4661-9. PubMed ID: 15269138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordination modes vs. antitumor activity: synthesis and antitumor activity of novel platinum(II) complexes of N-substituted amino dicarboxylic acids.
    Kim YS; Song R; Chung HC; Jun MJ; Sohn YS
    J Inorg Biochem; 2004 Jan; 98(1):98-104. PubMed ID: 14659638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.